boston pharmaceuticals gsk

News

GSK buys liver drug from Boston Pharmaceuticals

GSK buys liver drug from Boston Pharmaceuticals for up to $2 billion

GSK is acquiring an experimental medicine from a Cambridge biotech to shore up its drug pipeline and muscle into the promising field of liver therapies.

· 6h

STAT · 15h

GSK to buy experimental MASH drug for $1.2B upfront

· 14h · on MSN

GSK to buy liver disease drug for up to $2 billion

Pharmabiz29m

GSK to buy Boston Pharma’s efimosfermin, a phase III-ready potential best-in-class specialty medicine to treat and prevent progression of SLD

GSK to buy Boston Pharma’s efimosfermin, a phase III-ready potential best-in-class specialty medicine to treat and prevent progression of SLD: London, UK Thursday, May 15, 2025, ...

23h

GSK to buy efimosfermin for up to $2 billion

GSK will buy efimosfermin, a specialty medicine used to treat liver disease from Boston Pharmaceuticals, for up to $2 billion ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results

News

GSK buys liver drug from Boston Pharmaceuticals

Trending now